The critical role of p53 to limit cancer development is shown by that more than 50% of all cancers have inactivating mutations in TP53 (the gene encoding for p53 in human) and that congenital mutations in TP53 result in cancer with very high penetrance [6, 7]. The gene discussed is TP53; the disease is cancer.